Clinical Trial Update: A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses. [Phase 1]

View source ↗

Summary

Phase 1 healthy volunteer study of DPOC-4088 to assess blood concentrations, effects on blood clotting, and safety across multiple doses was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Stroke

Drugs mentioned

• DPOC-4088

Snippet

Sponsor: Diakron Pharmaceuticals | Conditions: Deep Vein Thrombosis Leg, Stroke (in Patients With Atrial Fibrillation) | Phase 1 | Status: TERMINATED